New Partnership Announcement: CMN x EDUGENE
- Aug. 5, 2025

New Partnership Announcement: CRISPR Medicine News x EDUGENE
CRISPR Medicine News (CMN) is excited to announce a strategic partnership between CMN and EDUGENE - coming together to advance CRISPR and biotechnology education across Africa.
Through this collaboration, CMN plan to:
- Share curated CRISPR content tailored for students and educators
- Support virtual internships and mentorship opportunities
- Co-host student innovation challenges - with the winner invited to the CRISPRMED26 Conference in Copenhagen, April 13-16, 2026
- Launch joint webinars, guest lectures, and highlight important news from the CRISPR field
Together, CMN and EDUGENE are laying the groundwork for a stronger, more connected biotech education ecosystem in Africa.
Stay tuned for more updates coming later in 2025.
Tags
CLINICAL TRIALS
IND Enabling
Phase I
Phase II
Phase III
Gastric Cancer and Colorectal Cancer, CRC, (NCT07166263)
Sponsors:
Base Therapeutics (Shanghai) Co., Ltd.
Sponsors:
Base Therapeutics (Shanghai) Co., Ltd.
IND Enabling
Phase I
Phase II
Phase III
Relapsed or Refractory Acute Myeloid Leukemia, AML, (NCT06541444)
Sponsors:
Base Therapeutics (Shanghai) Co., Ltd.
Sponsors:
Base Therapeutics (Shanghai) Co., Ltd.
IND Enabling
Phase I
Phase II
Phase III